Alert: A Powerful Small Cap Trend is Unfolding in India
Here is the latest financial fact sheet of STRIDES PHARMA SCIENCE. For more details, see the STRIDES PHARMA SCIENCE quarterly results and STRIDES PHARMA SCIENCE share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | -0.9 |
No. of shares | m | 91.91 |
1 Week | % | 3.4 |
1 Month | % | 4.9 |
1 Year | % | 136.6 |
52 week H/L | Rs | 914.0/346.4 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
STRIDES PHARMA SCIENCE EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 720 | 547 | 1,000 | 947 | 392 | |
Low | Rs | 334 | 271 | 304 | 305 | 263 | |
Sales per share (Unadj.) | Rs | 243.2 | 307.2 | 369.7 | 341.9 | 408.5 | |
Earnings per share (Unadj.) | Rs | 10.0 | 4.8 | 27.2 | -52.8 | -25.6 | |
Diluted earnings per share | Rs | 9.7 | 4.7 | 26.5 | -51.6 | -25.1 | |
Cash flow per share (Unadj.) | Rs | 23.1 | 24.2 | 50.2 | -26.9 | 1.4 | |
Dividends per share (Unadj.) | Rs | 3.00 | 14.00 | 2.50 | 0 | 1.50 | |
Adj. dividends per share | Rs | 2.92 | 13.64 | 2.44 | 0.00 | 1.47 | |
Avg Dividend yield | % | 0.6 | 3.4 | 0.4 | 0 | 0.5 | |
Book value per share (Unadj.) | Rs | 294.9 | 281.5 | 309.1 | 262.5 | 242.8 | |
Adj. book value per share | Rs | 287.4 | 274.4 | 301.6 | 256.4 | 238.6 | |
Shares outstanding (eoy) | m | 89.57 | 89.57 | 89.68 | 89.79 | 90.30 | |
Price / Sales ratio | x | 2.2 | 1.3 | 1.8 | 1.8 | 0.8 | |
Avg P/E ratio | x | 52.9 | 84.5 | 24.0 | -11.8 | -12.8 | |
P/CF ratio (eoy) | x | 22.8 | 16.9 | 13.0 | -23.3 | 239.6 | |
Price / Book Value ratio | x | 1.8 | 1.5 | 2.1 | 2.4 | 1.4 | |
Dividend payout | % | 30.1 | 289.2 | 9.2 | 0 | -5.9 | |
Avg Mkt Cap | Rs m | 47,194 | 36,648 | 58,465 | 56,177 | 29,603 | |
Total wages/salary | Rs m | 3,294 | 4,426 | 5,501 | 6,469 | 7,320 |
STRIDES PHARMA SCIENCE INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 21,784 | 27,520 | 33,159 | 30,703 | 36,884 | |
Other income | Rs m | 408 | 531 | 594 | 1,334 | 1,352 | |
Total revenues | Rs m | 22,192 | 28,051 | 33,753 | 32,036 | 38,236 | |
Gross profit | Rs m | 2,182 | 3,310 | 5,723 | -3,762 | 830 | |
Depreciation | Rs m | 1,174 | 1,737 | 2,063 | 2,330 | 2,433 | |
Interest | Rs m | 793 | 1,557 | 1,501 | 1,767 | 2,611 | |
Profit before tax | Rs m | 624 | 547 | 2,754 | -6,525 | -2,862 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | -269 | 113 | 317 | -1,783 | -553 | |
Profit after tax | Rs m | 893 | 434 | 2,438 | -4,743 | -2,309 | |
Gross profit margin | % | 10.0 | 12.0 | 17.3 | -12.3 | 2.2 | |
Effective tax rate | % | -43.0 | 20.7 | 11.5 | 27.3 | 19.3 | |
Net profit margin | % | 4.1 | 1.6 | 7.4 | -15.4 | -6.3 |
STRIDES PHARMA SCIENCE BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 30,487 | 23,706 | 28,172 | 33,618 | 31,353 | |
Current liabilities | Rs m | 26,622 | 25,449 | 27,383 | 34,117 | 29,902 | |
Net working cap to sales | % | 17.7 | -6.3 | 2.4 | -1.6 | 3.9 | |
Current ratio | x | 1.1 | 0.9 | 1.0 | 1.0 | 1.0 | |
Inventory Days | Days | 158 | 158 | 158 | 90 | 71 | |
Debtors Days | Days | 165 | 124 | 122 | 144 | 129 | |
Net fixed assets | Rs m | 47,581 | 35,810 | 39,996 | 33,989 | 31,300 | |
Share capital | Rs m | 895 | 896 | 897 | 898 | 903 | |
"Free" reserves | Rs m | 25,516 | 24,321 | 26,823 | 22,670 | 21,025 | |
Net worth | Rs m | 26,411 | 25,217 | 27,719 | 23,568 | 21,928 | |
Long term debt | Rs m | 18,065 | 6,039 | 8,826 | 8,356 | 11,398 | |
Total assets | Rs m | 78,068 | 59,532 | 68,168 | 67,607 | 63,734 | |
Interest coverage | x | 1.8 | 1.4 | 2.8 | -2.7 | -0.1 | |
Debt to equity ratio | x | 0.7 | 0.2 | 0.3 | 0.4 | 0.5 | |
Sales to assets ratio | x | 0.3 | 0.5 | 0.5 | 0.5 | 0.6 | |
Return on assets | % | 2.2 | 3.3 | 5.8 | -4.4 | 0.5 | |
Return on equity | % | 3.4 | 1.7 | 8.8 | -20.1 | -10.5 | |
Return on capital | % | 3.2 | 6.7 | 11.6 | -14.9 | -0.8 | |
Exports to sales | % | 58.3 | 53.4 | 51.1 | 60.7 | 46.7 | |
Imports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Exports (fob) | Rs m | 12,708 | 14,694 | 16,941 | 18,639 | 17,213 | |
Imports (cif) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx inflow | Rs m | 14,630 | 16,351 | 18,143 | 19,390 | 18,113 | |
Fx outflow | Rs m | 427 | 352 | 392 | 529 | 672 | |
Net fx | Rs m | 14,203 | 15,999 | 17,751 | 18,861 | 17,442 |
STRIDES PHARMA SCIENCE CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 601 | 2,048 | 4,814 | -2,578 | 444 | |
From Investments | Rs m | -1,485 | 13,062 | -5,208 | -1,187 | 3,025 | |
From Financial Activity | Rs m | 1,943 | -17,094 | -158 | 4,213 | -2,139 | |
Net Cashflow | Rs m | 1,097 | -1,837 | -564 | 449 | 1,328 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Arun Kumar | COMP SEC: Manjula Ramamurthy | YEAR OF INC: 1990 | BSE CODE: 532531 | FV (Rs): 10 | DIV YIELD (%): 0.2 |
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare STRIDES PHARMA SCIENCE With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Asian markets traded higher on Thursday following record close in Wall Street indices overnight and as investors assessed Japan GDP data.